775 results on '"Ranson, Marie"'
Search Results
2. A tEMTing target? Clinical and experimental evidence for epithelial-mesenchymal transition in the progression of cutaneous squamous cell carcinoma (a scoping systematic review)
3. PAI-1 Deficiency Drives Pulmonary Vascular Smooth Muscle Remodeling and Pulmonary Hypertension
4. Urokinase plasminogen activator as an anti-metastasis target: inhibitor design principles, recent amiloride derivatives, and issues with human/mouse species selectivity
5. Systematic evaluation of structure–property relationships and pharmacokinetics in 6-(hetero)aryl-substituted matched pair analogs of amiloride and 5-(N,N-hexamethylene)amiloride
6. Design, synthesis and evaluation of carbamate-linked uridyl-based inhibitors of human ST6Gal I
7. Illustrated State‐of‐the‐Art Capsules of the ISTH 2020 Congress
8. Human pregnancy zone protein stabilizes misfolded proteins including preeclampsia- and Alzheimer’s-associated amyloid beta peptide
9. Gene expression profiling of perineural invasion in head and neck cutaneous squamous cell carcinoma
10. Expression of cancer stem cell markers is prognostic in metastatic gastroesophageal adenocarcinoma
11. Mutational Patterns in Metastatic Cutaneous Squamous Cell Carcinoma
12. A phase I dose-escalation study of an all-in-one 5-fluorouracil and leucovorin co-formulation administered after failure of standard treatment.
13. PIK Your Poison: The Effects of Combining PI3K and CDK Inhibitors against Metastatic Cutaneous Squamous Cell Carcinoma In Vitro
14. Ion Transport and Inhibitor Binding by Human NHE1: Insights from Molecular Dynamics Simulations and Free Energy Calculations
15. Micro RNA Dysregulation in Keratinocyte Carcinomas: Clinical Evidence, Functional Impact, and Future Directions.
16. Safety and Efficacy of Oxaliplatin Doublet Adjuvant Chemotherapy in Elderly Patients With Stage III Colon Cancer
17. Quantification of ligand density and stoichiometry on the surface of liposomes using single-molecule fluorescence imaging
18. Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities
19. Analysis of clinically relevant somatic mutations in high-risk head and neck cutaneous squamous cell carcinoma
20. Sex as a Predictor of Response to Immunotherapy in Advanced Cutaneous Squamous Cell Carcinoma
21. PAI-1 Deficiency Drives Pulmonary Vascular Smooth Muscle Remodeling and Pulmonary Hypertension
22. Abstract PR12: High-dimensional spatial analysis of the tumor-microenvironment to determine metastatic disease progression and response and resistance to therapy in head and neck cancer
23. Amorphous protein aggregates stimulate plasminogen activation, leading to release of cytotoxic fragments that are clients for extracellular chaperones
24. PD-L1 expression predicts longer disease free survival in high risk head and neck cutaneous squamous cell carcinoma
25. p16 expression in cutaneous squamous cell carcinoma of the head and neck is not associated with integration of high risk HPV DNA or prognosis
26. EGFR and PI3K Signalling Pathways as Promising Targets on Circulating Tumour Cells from Patients with Metastatic Gastric Adenocarcinoma.
27. Ex vivo therapeutic screening of metastatic cSCC: A review of methodological considerations for clinical implementation.
28. Ion Transport and Inhibitor Binding by human NHE1: Insights from Molecular Dynamics Simulations and Free Energy Calculations
29. Automated Patch Clamp Screening of Amiloride and 5-N,N-Hexamethyleneamiloride Analogs Identifies 6-Iodoamiloride as a Potent Acid-Sensing Ion Channel Inhibitor
30. PZP and PAI-2: Structurally-diverse, functionally similar pregnancy proteins?
31. N-alkylated isatins evade P-gp mediated efflux and retain potency in MDR cancer cell lines
32. Establishment of novel long-term cultures from EpCAM positive and negative circulating tumour cells from patients with metastatic gastroesophageal cancer
33. Recent Advances in Targeting the Urokinase Plasminogen Activator with Nanotherapeutics
34. Supplementary Figure from High-Dimensional and Spatial Analysis Reveals Immune Landscape–Dependent Progression in Cutaneous Squamous Cell Carcinoma
35. Supplementary Table from High-Dimensional and Spatial Analysis Reveals Immune Landscape–Dependent Progression in Cutaneous Squamous Cell Carcinoma
36. Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU)
37. Gastric cancer stem cells: evidence, potential markers, and clinical implications
38. HER2-Positive Gastroesophageal Cancers Are Associated with a Higher Risk of Brain Metastasis
39. Selecting Australian marine macroalgae based on the fatty acid composition and anti-inflammatory activity
40. Improved Pharmacokinetic and Biodistribution Properties of the Selective Urokinase Inhibitor PAI-2 (SerpinB2) by Site-Specific PEGylation: Implications for Drug Delivery
41. Synthesis and anti-leukaemic activity of pyrrolo[3,2,1-hi]indole-1,2-diones, pyrrolo[3,2,1-ij]quinoline-1,2-diones and other polycyclic isatin derivatives
42. Different radiolabelling methods alter the pharmacokinetic and biodistribution properties of Plasminogen Activator Inhibitor Type 2 (PAI-2) forms
43. Anti-cancer activity of an acid-labile N-alkylisatin conjugate targeting the transferrin receptor
44. High-Dimensional and Spatial Analysis Reveals Immune Landscape–Dependent Progression in Cutaneous Squamous Cell Carcinoma
45. Whole genome analysis reveals the genomic complexity in metastatic cutaneous squamous cell carcinoma
46. Dependence on Endocytic Receptor Binding via a Minimal Binding Motif Underlies the Differential Prognostic Profiles of SerpinE1 and SerpinB2 in Cancer
47. Synthesis and hydrolytic evaluation of acid-labile imine-linked cytotoxic isatin model systems
48. Small molecule antagonists of the urokinase (uPA): urokinase receptor (uPAR) interaction with high reported potencies show only weak effects in cell-based competition assays employing the native uPAR ligand
49. Molecular competition between plasminogen activator inhibitors type -1 and -2 for urokinase: Implications for cellular proteolysis and adhesion in cancer
50. A tEMTing target? - Clinical and Experimental Evidence for Epithelial-Mesenchymal Transition in the Progression of Cutaneous Squamous Cell Carcinoma (A Scoping Systematic Review)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.